Out of stock
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
0 People recently viewed this
Linzolid IV
Incepta Pharmaceuticals Ltd.
Generic: Linezolid 0.2% Inj
Safety Advices
বাংলা
English
UNSAFE
It is unsafe to consume alcohol with Linzolid IV.
CONSULT YOUR DOCTOR
Linzolid IV may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
CONSULT YOUR DOCTOR
Linzolid IV is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
UNSAFE
Linzolid IV may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
SAFE IF PRESCRIBED
Linzolid IV is safe to use in patients with kidney disease. No dose adjustment of Linzolid IV is recommended.
However, talk to your doctor if you have any underlying kidney disease.
CAUTION
Linzolid IV should be used with caution in patients with severe liver disease. Dose adjustment of Linzolid IV may be needed. Please consult your doctor.
Limited information is available on the use of Linzolid IV in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Medicine Overview of Linzolid IV 0.20% Solution
Introduction
Linzolid IV is an antibiotic medicine used in the treatment of severe bacterial infections. It is used to treat infections of lungs (Pneumonia), skin and soft tissues. Linzolid IV may be taken with or without food, preferably at a fixed time. You should take it regularly as per the schedule prescribed by your doctor. Taking it at the same time every day will help you to remember to take it. Do not stop taking it until you have finished the complete course, even when you feel better. If you stop taking this medicine too early then infection may return or...
... Show moreUses of Linzolid IV
- Severe bacterial infections
Side effects of Linzolid IV
Common
- Vomiting
- Headache
- Nausea
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
How to use Linzolid IV
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Linzolid IV may be taken with or without food, but it is better to take it at a fixed time.
Avoid Linzolid IV with tyramine-rich food such as cheese, smoked fish, meats and some types of beer.
How Linzolid IV works
Linzolid IV is an antibiotic. It stops bacterial growth by preventing synthesis of essential proteins required by bacteria to carry out vital functions.
Quick Tips
- Linzolid IV treats serious infections caused by certain types of bacteria.
- Take it with food to avoid an upset stomach.
- Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection to come back and harder to treat.
- Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it doesn't stop or if you find blood in your stools.
- Avoid taking excessive cheese, processed meats, alcohol, or soy sauce while taking this medication as these may cause an excessive rise in your blood pressure.
- Inform your doctor if you develop fever, shortness of breath, or any changes in your vision.
- Do not take it for more than 14 days without consulting your doctor.
Brief Description
Indication
Community-acquired pneumonia, Skin and skin structure infections, Nosocomial pneumonia
Administration
Patients who commence treatment on the parenteral formulation may be switched to either oral presentation when clinically indicated. In such circumstances, no dose adjustment is required as Linzolid (Linezolid) has an oral bioavailability of approximately 100%. The injection should be administered over a period of 30 to 120 minutes.
Adult Dose
Intravenous
Vancomycin-resistant Enterococcus faecium
Adult: 600 mg 12 hrly for 14-28 days.
Methicillin-resistant Staphylococcus aureus infections
Adult: 600 mg bid for 7-21 days.
Community-acquired pneumonia; Nosocomial pneumonia; Complicated skin and skin structure infections
Adult: 600 mg 12 hrly for 10-14 days.
Elderly: No dosage adjustment needed.
Hepatic impairment: Mild to moderate: No dosage adjustment needed.
Child Dose
Intravenous
For Pediatric Patients
Pneumonia, complicated skin infections, vancomycin resistant enterococci:
Birth–11 y: 30 mg/kg/day q8h
>11 y: 1,200 mg/day q12h
Uncomplicated skin infections:
Birth–5 y: 30 mg/kg/day q8h
5–11 y: 20 mg/kg/day q12h
>11–18 y: 1,200 mg/day q12h
Contraindication
Linzolid formulations are contraindicated for use in patients who have known hypersensitivity to Linzolid or any of the other product components. Linzolid should not be used in patients taking any medicinal product which inhibits monoamine oxidases A or B (e.g. phenelzine, isocarboxazid) or within two weeks of taking any such medicinal product. Linzolid should not be administered to patients with uncontrolled hypertension, pheochromocytoma, thyrotoxicosis, carcinoid syndrome and/or patients taking directly and indirectly acting sympathomimetic agents (e.g. pseudoephedrine), vasopressive agents (e.g. epinephrine, norepinephrine), dopaminergic agents (e.g. dopamine, dobutamine), serotonin re-uptake inhibitors, tricyclic antidepressants, serotonin 5-HT1 receptor agonists (triptans), meperidine or buspirone.
Mode of Action
Linezolid is a bacteriostatic oxazolidinone which acts by inhibiting ribosomal protein synthesis. It is active against gm+ve bacteria including vancomycin-resistant enterococci and MRSA. It has limited in vitro activity against gm-ve bacteria.
Precaution
Preexisting myelosuppression, renal impairment (CrCl < 30ml/min), uncontrolled hypertension, phaeochromocytoma, carcinoid syndrome, untreated hyperthyroidism, chronic infection, history of seizures, bipolar depression, schizophrenia or acute confusional states. Pregnancy and lactation. Monitor complete blood counts weekly. Give after haemodialysis. Not known if linezolid or metabolites removed during peritoneal dialysis.
Lactation: Unknown; use caution
Side Effect
>10%
Pediatrics
Diarrhea (7.8-10.8%)
1-10%
Headache (5.7-8.8%).Diarrhea (8.2-8.3%),Nausea (5.1-6.6%),Vomiting (2-4.3%),Dizziness (1.8-2.6%),Rash (1.1-2.3%),Vaginal moniliasis (1.1-1.8%),Taste alteration (1-1.8%),Oral moniliasis (0.5-1.7%),Abnormal LFTs (0.4-1.6%),Fungal infection (0.3-1.5%),Localized abdominal pain (1.2-1.3%),Tongue discoloration (0.3-1.3%),Generalized abdominal pain (0.9-1.2%)
Pediatrics
Vomiting (2.9-9.4%),Headache (0.9-6.5%),Anemia (5.6%),Thrombocytopenia (4.7%),Nausea (1.9-3.7%),Generalized abdominal pain (0.9-2.4%),Localized abdominal pain (0.5-2.4%),Loose stools (1.6-2.3%),Eosinophilia (0.4-1.9%),Pruritus, other than application site (0.8-1.4%),Vertigo (1.2%)
10-14 days), transient ischaemic attacks, renal failure, Stevens-Johnson syndrome.
Interaction
May reduce serum levels w/ rifampicin and phenytoin. May cause hypoglycaemia w/ insulin or oral antidiabetics. May increase risk of seizures w/ tramadol.
Potentially Fatal: Increased risk of serotonin syndrome w/ MAOIs, TCAs, SNRIs, or other serotonergic drugs (e.g. bupropion, vilazodone, mirtazapine, amoxapine, buspirone, maprotiline, meperidine, trazodone, nefazodone). Significant increase in BP w/ vasopressive agents (e.g. epinephrine, norepinephrine), sympathomimetic agents (e.g. pseudoephedrine) and dopaminergic agents (e.g. dopamine, dobutamine).
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
